LF
BIIB icon

Lansforsakringar Fondforvaltning’s Biogen BIIB Stock Holding History

Lansforsakringar Fondforvaltning’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.76M Sell
47,807
-918
-2% -$169K 0.05% 303
2025
Q4 		$8.58M Buy
48,725
+417
+0.9% +$68.1K 0.04% 312
2025
Q3 		$6.77M Buy
48,308
+561
+1% +$75.8K 0.04% 344
2025
Q2 		$6M Sell
47,747
-385
-0.8% -$48K 0.03% 362
2025
Q1 		$6.59M Sell
48,132
-130
-0.3% -$18.6K 0.04% 341
2024
Q4 		$7.38M Buy
+48,262
New +$8.14M 0.04% 331

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Lansforsakringar Fondforvaltning's BIIB Position: Q1 2026 in Review

Lansforsakringar Fondforvaltning reduced its Biogen (BIIB) stake by 1.9% in Q1 2026, selling an estimated $169K and leaving 47,807 shares worth $8.76M. The position accounts for 0.05% of the portfolio, ranked #303.

Lansforsakringar Fondforvaltning first reported a position in BIIB in Q4 2024 and has held it in 6 quarters since. 1,003 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Lansforsakringar Fondforvaltning held 47,807 shares of Biogen worth $8.76M as of Q1 2026.
  • Lansforsakringar Fondforvaltning sold 918 Biogen shares in Q1 2026, an estimated $169K.
  • Biogen made up 0.05% of Lansforsakringar Fondforvaltning's portfolio in Q1 2026, its #303 holding.
  • Lansforsakringar Fondforvaltning first reported a position in Biogen in Q4 2024 and has held it in 6 quarters since.
  • 1,003 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Lansforsakringar Fondforvaltning's 13F filing for Q1 2026, filed 23 Apr 2026.